Could nanoparticle corona characterization help for biological consequence prediction?

Cancer Nanotechnology

Volumn 5, Issue 1, 2014, Pages

  Brun, Emilie ^a   Sicard – Roselli, Cécile ^a  

^a UNIVERSITÉ PARIS SUD   (France)

Author keywords

Cellular interaction; Culture medium; Gold nanoparticles; Hydrodynamic size; Nanoparticle toxicity; Nanoparticle uptake; Protein corona; Protein identification

Indexed keywords

ALBUMIN; CELL PROTEIN; CORONA PROTEIN; FIBRINOGEN; GLYCOPROTEIN; GOLD NANOPARTICLE; IMMUNOGLOBULIN; NANOMATERIAL; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CELL INTERACTION; DENSITY GRADIENT; DIFFERENTIAL CENTRIFUGAL SEDIMENTATION; DYNAMIC LIGHT SCATTERING; HYDRODYNAMICS; LIGHT SCATTERING; MASS SPECTROMETRY; NANOPARTICLE TRACKING ANALYSIS; PARTICLE SIZE; PROTEIN ANALYSIS; PROTEOMICS; SEDIMENTATION; STATIC ELECTRICITY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; ZETA POTENTIAL;

EID: 84915753425     PISSN: 18686958     EISSN: 18686966     Source Type: Journal    
DOI: 10.1186/s12645-014-0007-5     Document Type: Article

References (78)

1. Lange CFA (1913) Über die Ausflockung kolloidalen Goldes durch Zerebrospinalflüssigket bei luetischen Affektionen des Zentralnervensystems. Zeitschrift für Chemotherapie und verwandte Gebiete 1:44–78
2. Ahmad MZ, Akhter S, Rahman Z, Akhter S, Anwar M, Mallik N, Ahmad FJ (2013) Nanometric gold in cancer nanotechnology: current status and future prospect. J Pharm Pharmacol 65:634–651
3. Boisselier E, Astruc D (2009) Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38:1759–1782
4. Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA (2012) The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41:2740–2779
5. Kumar D, Saini N, Jain N, Sareen R, Pandit V (2013) Gold nanoparticles: an era in bionanotechnology. Expert Opin Drug Deliv 10:397–409
6. Cobley CM, Chen J, Cho EC, Wang LV, Xia Y (2011) Gold nanostructures: a class of multifunctional materials for biomedical applications. Chem Soc Rev 40:44–56
7. Jiao PF, Zhou HY, Chen LX, Yan B (2011) Cancer-targeting multifunctionalized gold nanoparticles in imaging and therapy. Curr Med Chem 18:2086–2102
8. Mieszawska AJ, Mulder WJ, Fayad ZA, Cormode DP (2013) Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm 10:831–847
9. Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3:40–47
10. Rahman M, Laurent S, Tawil N, Yahia L, Mahmoudi M (2013) Protein-Nanoparticle Interactions. Springer, Berlin Heidelberg
11. Saptarshi SR, Duschl A, Lopata AL (2013) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol 11:26
12. Walkey CD, Chan WCW (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41:2780–2799
13. Lin PC, Lin S, Wang PC, Sridhar R (2014) Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv 32:711–726
14. Herrera J, Sakulchaicharoen N (2009) Microscopic And Spectroscopic Characterization Of Nanoparticles. In: Pathak Y, Thassu D (eds) Nanoparticulate Drug Delivery Systems. Informa Healthcare, New York, pp 237–249
15. Klang V, Valenta C, Matsko NB (2013) Electron microscopy of pharmaceutical systems. Micron 44:45–74
16. McDonald KL (2014) Out with the old and in with the new: rapid specimen preparation procedures for electron microscopy of sectioned biological material. Protoplasma 251:429–448
17. Pluchery O (2012) Optical Properties of Gold Nanoparticles. In: Louis C, Pluchery O (eds) Gold Nanoparticles for Physics, Chemistry and Biology. London: Imperial College Press; pp 43–73
18. Haiss W, Thanh NTK, Aveyard J, Fernig DG (2007) Determination of size and concentration of gold nanoparticles from UV–vis spectra. Anal Chem 79:4215–4221
19. Brun E, Sanche L, Sicard-Roselli C (2009) Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution. Colloids Surf B: Biointerfaces 72:128–134
20. He YQ, Liu SP, Kong L, Liu ZF (2005) A study on the sizes and concentrations of gold nanoparticles by spectra of absorption, resonance Rayleigh scattering and resonance non-linear scattering. Spectrochim Acta, Pt A: Mol Spectrosc 61:2861–2866
21. Link S, El-Sayed MA (1999) Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J Phys Chem B 103:4212–4217
22. Nath N, Chilkoti A (2004) Label-free biosensing by surface plasmon resonance of nanoparticles on glass: optimization of nanoparticle size. Anal Chem 76:5370–5378
23. Brar SK, Verma M (2011) Measurement of nanoparticles by light-scattering techniques. Trac-Trend Anal Chem 30:4–17
24. Roebben G, Ramirez-Garcia S, Hackley VA, Roesslein M, Klaessig F, Kestens V, Lynch I, Garner CM, Rawle A, Elder A Colvin VL, Kreyling W, Krug HF, Lewicka ZA, McNeil S, Nel A, Patri A, Wick P, Wiesner M, Xia T, Oberdorster G, Dawson KA (2011) Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment. J Nanopart Res 13:2675–2687
25. Filipe V, Hawe A, Jiskoot W (2010) Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm Res 27:796–810
26. Hole P, Sillence K, Hannell C, Maguire CM, Roesslein M, Suarez G, Capracotta S, Magdolenova Z, Horev-Azaria L, Dybowska A, Cooke L, Haase A, Contal S, Mano S, Vennemann A, Sauvain JJ, Staunton KC, Anguissola S, Luch A, Dusinska M, Korenstein R, Gutleb AC, Wiemann M, Prina-Mello A, Riediker M, Wick P (2013) Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA). J Nanopart Res 15(12)ᅟ doi 10.1007/S11051-013-2101-8
27. Krpetic Z, Davidson AM, Volk M, Levy R, Brust M, Cooper DL (2013) High-resolution sizing of monolayer-protected gold clusters by differential centrifugal sedimentation. ACS Nano 7:8881–8890
28. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA (2011) Physical-chemical aspects of protein corona: relevance to in Vitro and in Vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–2534
29. Jedlovszky-Hajdu A, Bombelli FB, Monopoli MP, Tombacz E, Dawson KA (2012) Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir 28:14983–14991
30. Hinterwirth H, Wiedmer SK, Moilanen M, Lehner A, Allmaier G, Waitz T, Lindner W, Lammerhofer M (2013) Comparative method evaluation for size and size-distribution analysis of gold nanoparticles. J Sep Sci 36:2952–2961
31. Khlebtsov BN, Khlebtsov NG (2011) On the measurement of gold nanoparticle sizes by the dynamic light scattering method. Colloid J 73:118–127
32. Schaffler M, Semmler-Behnke M, Sarioglu H, Takenaka S, Wenk A, Schleh C, Hauck SM, Johnston BD, Kreyling WG (2013) Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology 24:265103
33. Sabuncu AC, Grubbs J, Qian S, Abdel-Fattah TM, Stacey MW, Beskok A (2012) Probing nanoparticle interactions in cell culture media. Colloids Surf B: Biointerfaces 95:96–102
34. Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, Cingolani R, Pompa PP (2010) Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 4:7481–7491
35. Wang G, Papasani MR, Cheguru P, Hrdlicka PJ, Hill RA (2012) Gold-peptide nanoconjugate cellular uptake is modulated by serum proteins. Nanomed Nanotechnol Biol Med 8:822–832
36. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V (2010) Time evolution of the nanoparticle protein corona. ACS Nano 4:3623–3632
37. Mahmoudi M, Abdelmonem AM, Behzadi S, Clement JH, Dutz S, Ejtehadi MR, Hartmann R, Kantner K, Linne U, Maffre P, Metzler S, Moghadam MK, Pfeiffer C, Rezaei M, Ruiz-Lozano P, Serpooshan V, Shokrgozar MA, Nienhaus GU, Parak WJ (2013) Temperature: the “ignored” factor at the nanobio interface. ACS Nano 7:6555–6562
38. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134:2139–2147
39. Dobrovolskaia MA, Neun BW, Man S, Ye X, Hansen M, Patri AK, Crist RM, McNeil SE (2014) Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. Nanomedicine, doi:10.1016/j.nano.2014.01.009
40. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE (2009) Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106–117
41. Walkey CD, Olsen JB, Guo HB, Emili A, Chan W (2012) Nanoparticle size and PEG grafting density control protein adsorption and cellular interactions in a physiological environment. Abstr Pap Am Chem S 243,ᅟWOS:000324475104157.
42. Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DW, Cohen Y, Emili A, Chan WC (2014) Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8:2439–2455
43. Pozzi D, Colapicchioni V, Caracciolo G, Piovesana S, Capriotti AL, Palchetti S, De Grossi S, Riccioli A, Amenitsch H, Lagana A (2014) Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale 6:2782–2792
44. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5:7155–7167
45. Sisco PN, Wilson CG, Chernak D, Clark JC, Grzincic EM, Ako-Asare K, Goldsmith EC, Murphy CJ (2014) Adsorption of cellular proteins to polyelectrolyte-functionalized gold nanorods: a mechanism for nanoparticle regulation of cell phenotype? PLoS one 9.ᅟ doi 10.1371/journal.pone.0086670
46. Albanese A, Walkey CD, Olsen JB, Guo H, Emili A, Chan W (2014) Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. ACS Nano 8:5515–5526
47. Patel PC, Giljohann DA, Daniel WL, Zheng D, Prigodich AE, Mirkin CA (2010) Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconj Chem 21:2250–2256
48. Jiang X, Weise S, Hafner M, Rocker C, Zhang F, Parak WJ, Nienhaus GU (2010) Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J R Soc Lond Interface 7(Suppl 1):S5–S13
49. Treuel L, Brandholt S, Maffre P, Wiegele S, Shang L, Nienhaus GU (2014) Impact of protein modification on the protein corona on nanoparticles and nanoparticle-cell interactions. ACS Nano 8:503–513
50. Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A (2012) Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845–5857
51. Lesniak A, Salvati A, Santos-Martinez MJ, Radomski MW, Dawson KA, Aberg C (2013) Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc 135:1438–1444
52. Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, Nienhaus GU, Musyanovych A, Mailander V, Landfester K, Simmet T (2011) Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5:1657–1669
53. Peng Q, Zhang S, Yang Q, Zhang T, Wei XQ, Jiang L, Zhang CL, Chen QM, Zhang ZR, Lin YF (2013) Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34:8521–8530
54. Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson KA (2010) Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31:9511–9518
55. Yan Y, Gause KT, Kamphuis MM, Ang CS, O’Brien-Simpson NM, Lenzo JC, Reynolds EC, Nice EC, Caruso F (2013) Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines. ACS Nano 7:10960–10970
56. Krais A, Wortmann L, Hermanns L, Feliu N, Vahter M, Stucky S, Mathur S, Fadeel B (2014) Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum. Nanomed Nanotechnol Biol Med, doi:10.1016/j.nano.2014.01.006
57. Prapainop K, Witter DP, Wentworth P (2012) A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins. J Am Chem Soc 134:4100–4103
58. Caracciolo G, Cardarelli F, Pozzi D, Salomone F, Maccari G, Bardi G, Capriotti AL, Cavaliere C, Papi M, Lagana A (2013) Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles. ACS Appl Mater Interfaces 5:13171–13179
59. Ge C, Du J, Zhao L, Wang L, Liu Y, Li D, Yang Y, Zhou R, Zhao Y, Chai Z, Chen C (2011) Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U S A 108:16968–16973
60. Hu W, Peng C, Lv M, Li X, Zhang Y, Chen N, Fan C, Huang Q (2011) Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5:3693–3700
61. Wang F, Yu L, Monopoli MP, Sandin P, Mahon E, Salvati A, Dawson KA (2013) The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine 9:1159–1168
62. Wang L, Li J, Pan J, Jiang X, Ji Y, Li Y, Qu Y, Zhao Y, Wu X, Chen C (2013) Revealing the binding structure of the protein corona on gold nanorods using synchrotron radiation-based techniques: understanding the reduced damage in cell membranes. J Am Chem Soc 135:17359–17368
63. Doorley GW, Payne CK (2012) Nanoparticles act as protein carriers during cellular internalization. Chem Commun (Camb) 48:2961–2963
64. Speshock JL, Braydich-Stolle LK, Szymanski ER, Hussain SM (2011) Silver and gold nanoparticles alter cathepsin activity in vitro. Nanoscale Res Lett 6,ᅟ doi 10.1007/S11671-010-9746-3
65. Vauthier C, Persson B, Lindner P, Cabane B (2011) Protein adsorption and complement activation for di-block copolymer nanoparticles. Biomaterials 32:1646–1656
66. Deng ZJ, Liang MT, Monteiro M, Toth I, Minchin RF (2011) Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotech 6:39–44
67. Cifuentes-Rius A, de Puig H, Kah JCY, Borros S, Hamad-Schifferli K (2013) Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release. ACS Nano 7:10066–10074
68. Kah JCY, Chen J, Zubieta A, Hamad-Schifferli K (2012) Exploiting the protein corona around gold nanorods for loading and triggered release. ACS Nano 6:6730–6740
69. Faure AC, Dufort S, Josserand V, Perriat P, Coll JL, Roux S, Tillement O (2009) Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small 5:2565–2575
70. Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Kissel T, Parak WJ, Kreyling WG (2010) Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31:6574–6581
71. Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Controlled Release 114:343–347
72. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11:169–183
73. Ogawara K, Furumoto K, Nagayama S, Minato K, Higaki K, Kai T, Kimura T (2004) Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J Controlled Release 100:451–455
74. Schaffler M, Sousa F, Wenk A, Sitia L, Hirn S, Schleh C, Haberl N, Violatto M, Canovi M, Andreozzi P, Salmona M, Bigini P, Kreyling WG, Krol S (2014) Blood protein coating of gold nanoparticles as potential tool for organ targeting. Biomaterials 35:3455–3466
75. Kratz F (2014) A clinical update of using albumin as a drug vehicle - a commentary. J Controlled Release, doi:10.1016/j.jconrel.2014.03.013
76. Mirshafiee V, Mahmoudi M, Lou K, Cheng J, Kraft ML (2013) Protein corona significantly reduces active targeting yield. Chem Commun (Camb) 49:2557–2559
77. Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, Kelly PM, Aberg C, Mahon E, Dawson KA (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotech 8:137–143
78. Dai Q, Walkey C, Chan WCW (2014) Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. Angew Chem Int Edit 53:5093–5096